Zoll's Propaq MD monitor/defibrillator cleared in US
This article was originally published in Clinica
The US FDA has granted 510(k) clearance for Zoll Medical's Propaq MD monitor/defibrillator, designed for military use. The device is 60% smaller and 40% lighter than similar monitor/defibrillators, Zoll (Chelmsford, Massachusetts) claims. It is also 0.9kg lighter than the firm's current military vital signs monitor, the Propaq 206, which does not include defibrillation and pacing capabilities like Propaq MD. The new system also has a night vision goggle mode. Propaq MD was developed using grants from the US Army Medical Research and Development Command, in collaboration with the US Department of Defense and Welch Allyn.
You may also be interested in...
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.